<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431922</url>
  </required_header>
  <id_info>
    <org_study_id>ED treatment</org_study_id>
    <nct_id>NCT03431922</nct_id>
  </id_info>
  <brief_title>Endovascular Denervation in Patients With Cancer Pain</brief_title>
  <official_title>Endovascular Denervation in Patients With Cancer Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongda Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endovascular arterial denervation (ED) is a minimally invasive technique which could reduce
      the occurrence of injury of visceral tissue or organs. As the principle of renal denervation
      (RDN), Radiofrequency energy delivered by a multi-electrode catheter to the celiac plexus
      over the anterolateral surface of the superior mesenteric artery (SMA) and the celiac axis.
      Damaged or partially damaged celiac plexus can achieve the effect of pain relief.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The multi-electrode catheter was consisted of six independent electrodes helically on a net
      structure, which could be set as the same energy and temperature for simultaneous multi-point
      ablation. A real-time monitoring capability also provided by the display.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>from baseline to 1 months after procedure</time_frame>
    <description>Changes of the visual analogue scores (VAS) scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>from baseline to 3 months after procedure</time_frame>
    <description>Changes of the visual analogue scores (VAS) scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of Quality of Life</measure>
    <time_frame>from baseline to 3 months after procedure</time_frame>
    <description>Changes of the 100-item World Health Organization Quality of Life (QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Treatment Adverse Events</measure>
    <time_frame>from baseline to 1 months after procedure</time_frame>
    <description>Assess artery damage, such as abdominal aortic dissection and abdominal aneurysm, by digital subtraction angiography or computed tomography</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>endovascular denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endovascular denervation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>endovascular denervation</intervention_name>
    <description>multi-electrode catheter-based endovascular denervation</description>
    <arm_group_label>endovascular denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  25 to 75 years

          -  severe cancer pain with the visual analogue scores of no less than 7

        Exclusion Criteria:

          -  pregnant or intent to become pregnant within 1 year

          -  postural hypotension

          -  uncorrected coagulation dysfunction

          -  aortic aneurysm or dissection

          -  type 1 diabetes mellitus (T1DM)

          -  acute or severe systemic infection

          -  history of cerebral apoplexy or transient ischemic attack (TIA) in the past two weeks

          -  history of acute coronary syndrome in the past two weeks

          -  participants who are not suitable to be enrolled into the study assessed by the
             researchers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gao-Jun Teng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongda Hospital, Southeast University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gao-Jun Teng, MD</last_name>
    <phone>+86 25 83272121</phone>
    <email>gjteng@seu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qi Zhang, PhD</last_name>
    <phone>+86-15312027895</phone>
    <email>dnzhangqi@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital, Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gao-Jun Teng, MD</last_name>
      <phone>+86 25 83272121</phone>
      <email>gjteng@seu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Qi Zhang, PhD</last_name>
      <phone>+86-15312027895</phone>
      <email>dnzhangqi@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain. 2004 Jul;110(1-2):400-8.</citation>
    <PMID>15275792</PMID>
  </reference>
  <reference>
    <citation>Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Mantilla CB, Warner DO. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004 Mar 3;291(9):1092-9.</citation>
    <PMID>14996778</PMID>
  </reference>
  <reference>
    <citation>Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994 Mar 3;330(9):592-6.</citation>
    <PMID>7508092</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongda Hospital</investigator_affiliation>
    <investigator_full_name>Gao-jun Teng</investigator_full_name>
    <investigator_title>Dean</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

